Go Back

PHARMA

Our rapidly increasing portfolio of over 400 products spreads across a wide spectrum of therapeutic categories carefully selected in a strategic methodology of needs based segmentation for our markets consumer needs. We continue to invest rapidly in Product Development to expand our offering to the needs of our expanding new markets penetration objectives.

​

The current marketed export portfolio can be downloaded in the following link:

​

​

​

​

​

​